Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 751-756

  Calingasan, Noel Y ^b   Uchida, Koji ^a   Gibson, Gary E ^b  

^a NAGOYA UNIVERSITY   (Japan)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Acrolein; Alzheimer's disease; Hydroxynonenal; Lipid peroxidation; Neurofibrillary tangles; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; ACROLEIN; AMYLOID BETA PROTEIN; BIOCHEMICAL MARKER; CARBONYL DERIVATIVE; KEYHOLE LIMPET HEMOCYANIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHY; OXIDATIVE STRESS; PAIRED HELICAL FILAMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MODIFICATION;

EID: 0032905632     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720751.x     Document Type: Article

References (29)

1. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
2. Berlett B. S. and Stadtman E. R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272, 20313-20316.
3. Daugherty A., Dunn J. L., Rateri D. L., and Heinecke J. W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444.
4. Esterbauer H., Schaur R. J., and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
5. Furuta A., Price D. L., Pardo C. A., Troncoso J. C., Xu Z. S., Taniguchi N., and Martin L. J. (1995) Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am. J. Pathol. 146, 357-367.
6. Gan J. C., Oandasan A., and Ansari G. A. (1991) In vitro modification of serum albumin by acrolein. Chemosphere 23, 939-947.
7. Greenberg S. G. and Davies P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87, 5827-5831.
8. Guntern R., Bouras C., Hof P. R., and Valet P. G. (1992) An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48, 8-10.
9. He Y., Nagano M., Yamamoto H., Miyamoto E., and Futatsuka M. (1995) Modifications of neurofilament proteins by possible metabolites of allyl chloride in vitro. Drug Chem. Toxicol. 18, 315-331.
10. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad Sci. USA 91, 3270-3274.
11. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Lovell M., Markesbery W. R., and Butterfield D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
12. Horton N. D., Mamiya B. M., and Kehrer J. P. (1997) Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. Toxicology 122, 111-122.
13. Jolivalt C., Leininger-Muller B., Drozdz R., Naskalski J. W., and Siest G. (1996) Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci. Lett. 210, 61-64.
14. Markesbery W. R. and Ehmann W. D. (1993) Brain trace elements in Alzheimer's disease, in Alzheimer's Disease (Terry R. D., Katzman R., and Bick R., eds), p. 367. Raven Press, New York.
15. Mecocci P., MacGarvey U., and Beal M. F. (1993) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
16. Pappolla M. A., Omar R. A., Kim K. S., and Robakis N. K. (1992) Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am. J. Pathol. 140, 621-628.
17. Pappolla M. A., Chyan Y. J., Omar R. A., Hsiao K., Perry G., Smith M. A., and Bozner P. (1998) Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152, 871-877.
18. Savenkova M. I., Mueller D. M., and Heinecke J. W. (1994) Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoproteins. J. Biol. Chem. 269, 20394-20400.
19. Sayre L. M., Zelasko D. A., Harris P. L. R., Perry G., Salomon R. G., and Smith M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097.
20. Schipper H. M., Cissé S., and Stopa E. G. (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer disease brain. Ann. Neurol. 37, 758-768.
21. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
22. Smith M. A., Kutty R. K., Richey P. L., Yan S. D., Stern D., Chader G. J., Wiggert B., Petersen R. B., and Perry G. (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145, 42-47.
23. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F., and Kowall N. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
24. Smith M. A., Harris P. L., Sayre L. M., and Perry G. (1997) Iron accumulation in Alzheimer's disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94, 9866-9868.
25. Smith M. A., Hirai K., Hsiao K., Pappolla M. A., Harris P. L. R., Siedlak S. L., Tabaton M., and Perry G. (1998) Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70, 2212-2215.
26. Uchida K., Szweda L. I., Chae H. Z., and Stadtman E. R. (1993) Immunochemical detection of 4-hydroxy-2-nonenal-modified proteins in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA 90, 8742-8746.
27. Uchida K., Kanematsu M., Motimitsu Y., Osawa T., Noguchi N., and Niki E. (1998a) Acrolein is a product of lipid peroxidation: formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273, 16058-16066.
28. Uchida K., Kanematsu M., Sakai K., Matsuda T., Yasuda Y., Miyata T., Noguchi N., Niki E., and Osawa T. (1998b) Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA 95, 4882-4887.
29. Yan S.-D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y.-S., Scott C. W., Caputo C., Frappier T., Smith M. A., Perry G., Yen S.-H., and Stern D. (1994) Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA 91, 7787-7791.